Teligent Inc (NASDAQ:TLGT)’s share price traded down 6.3% on Friday . The stock traded as low as $2.95 and last traded at $2.97. 679,376 shares traded hands during trading, an increase of 5% from the average session volume of 648,869 shares. The stock had previously closed at $3.17.
Several equities analysts recently weighed in on the stock. Canaccord Genuity set a $4.00 price target on shares of Teligent and gave the company a “hold” rating in a research report on Thursday, March 15th. Zacks Investment Research upgraded shares of Teligent from a “sell” rating to a “hold” rating in a research report on Tuesday, March 13th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $7.00.
The stock has a market cap of $169.59, a price-to-earnings ratio of -15.63 and a beta of 0.72. The company has a debt-to-equity ratio of 2.70, a quick ratio of 2.01 and a current ratio of 2.68.
Teligent (NASDAQ:TLGT) last released its quarterly earnings data on Thursday, March 15th. The company reported ($0.08) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.13) by $0.05. The business had revenue of $16.10 million for the quarter, compared to the consensus estimate of $13.54 million. Teligent had a negative net margin of 18.42% and a negative return on equity of 14.55%. equities analysts forecast that Teligent Inc will post -0.03 earnings per share for the current fiscal year.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Two Sigma Investments LP purchased a new stake in Teligent during the fourth quarter valued at about $123,000. Wells Fargo & Company MN lifted its holdings in Teligent by 52.4% during the third quarter. Wells Fargo & Company MN now owns 49,264 shares of the company’s stock valued at $331,000 after purchasing an additional 16,937 shares during the last quarter. UBS Asset Management Americas Inc. lifted its holdings in Teligent by 282.7% during the fourth quarter. UBS Asset Management Americas Inc. now owns 51,034 shares of the company’s stock valued at $185,000 after purchasing an additional 37,700 shares during the last quarter. Schwab Charles Investment Management Inc. lifted its holdings in Teligent by 26.1% during the fourth quarter. Schwab Charles Investment Management Inc. now owns 74,300 shares of the company’s stock valued at $270,000 after purchasing an additional 15,400 shares during the last quarter. Finally, Deutsche Bank AG lifted its holdings in Teligent by 82.5% during the fourth quarter. Deutsche Bank AG now owns 90,938 shares of the company’s stock valued at $329,000 after purchasing an additional 41,119 shares during the last quarter. 68.24% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION NOTICE: This report was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this report on another site, it was copied illegally and republished in violation of United States and international copyright legislation. The legal version of this report can be viewed at https://www.dispatchtribunal.com/2018/04/08/teligent-tlgt-shares-down-6-3.html.
Teligent, Inc is a specialty generic pharmaceutical company. Under the Company’s own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 16 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2016.
Receive News & Ratings for Teligent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent and related companies with MarketBeat.com's FREE daily email newsletter.